Ticker Details
EyePoint Pharmaceuticals, Inc. Common Stock
IPO Date:	February 1, 2005
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$458.65M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 4.21%
Avg Daily Range (30 D):	$0.79 | 6.55%
Avg Daily Range (90 D):	$0.52 | 4.14%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	3.94M
Avg Daily Volume (90 D):	1.96M

Trade Size
Avg Trade Size (Sh.):	118
Avg Trade Size (Sh.) (30 D):	123
Avg Trade Size (Sh.) (90 D):	95

Institutional Trades
Total Institutional Trades:	1,159
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$1.72M
Avg Institutional Trade (90 D):	$1.78M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.81M
Avg Closing Trade (30 D):	$2.68M
Avg Closing Trade (90 D):	$2.28M
Avg Closing Volume:	139.42K

News

Jun 16, 2026 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Na

May 19, 2026 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Na

May 6, 2026 @ 11:00 AM EyePoint Reports First Quarter 2026 Financial Resu... Source: Eyepoint, Inc.

Mar 16, 2026 @ 10:23 PM This Biotech Stock Up 700% Is Still a Top Holding ... Source: Jonathan Ponciano

Mar 16, 2026 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.09	$-.99	$-.82
Diluted EPS	$-1.09	$-.99	$-.82
Revenue	$.51M	$.7M	$.62M
Gross Profit
Net Income / Loss	$-94.47M	$-84.83M	$-67.61M
Operating Income / Loss	$-97.38M	$-87.23M	$-70.35M
Cost of Revenue
Net Cash Flow	$32.75M	$-24.11M	$27.24M
PE Ratio

Splits
Dec 09, 2020	1:10
Jun 11, 2008	1:4